Oncobiologics - Investor Overview

Regulatory and Clinical Development. GMP Manufacturing Facility Tour. Oncobiologics is a clinical stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex biosimilar therapeutics. Our current focus is on technically challenging and commercially attractive monoclonal antibodies mAbs, in the disease areas of immunology and oncology. Our strategy is to leverage our BioSymphony Platform to cost-effectively develop these biosimilars on an accelera.

OVERVIEW

This site ir.oncobiologics.com currently has an average traffic classification of zero (the smaller the more traffic). We have explored zero pages within the site ir.oncobiologics.com and found forty-two websites linking to ir.oncobiologics.com.
Links to this site
42

IR.ONCOBIOLOGICS.COM RANKINGS

This site ir.oncobiologics.com has seen variant quantities of traffic for the whole of the year.
Traffic for ir.oncobiologics.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for ir.oncobiologics.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for ir.oncobiologics.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO WEB SITE

Oncobiologics - Targeting Healthy Outcomes

Oncobiologics Reports First Quarter Fiscal Year 2018 Results more. Oncobiologics Receives Positive Nasdaq Listing Determination more. Oncobiologics Announces Term Extension Of Series A Warrants more. Oncobiologics Announces Closing Of Strategic Partnership Deal With GMS Tenshi Holdings more. Oncobiologics announces strategic partnership with GMS Tenshi Holdings Pte.

WHAT DOES IR.ONCOBIOLOGICS.COM LOOK LIKE?

Desktop Screenshot of ir.oncobiologics.com Mobile Screenshot of ir.oncobiologics.com Tablet Screenshot of ir.oncobiologics.com

IR.ONCOBIOLOGICS.COM HOST

We detected that a single root page on ir.oncobiologics.com took one thousand one hundred and seventy-two milliseconds to download. Our parsers could not detect a SSL certificate, so therefore our web crawlers consider ir.oncobiologics.com not secure.
Load time
1.172 secs
SSL
NOT SECURE
Internet Protocol
23.12.41.9

WEBSITE IMAGE

PAGE TITLE

Oncobiologics - Investor Overview

DESCRIPTION

Regulatory and Clinical Development. GMP Manufacturing Facility Tour. Oncobiologics is a clinical stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex biosimilar therapeutics. Our current focus is on technically challenging and commercially attractive monoclonal antibodies mAbs, in the disease areas of immunology and oncology. Our strategy is to leverage our BioSymphony Platform to cost-effectively develop these biosimilars on an accelera.

CONTENT

This site ir.oncobiologics.com has the following in the homepage, "Oncobiologics is a clinical stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex biosimilar therapeutics." We observed that the website also stated " Our current focus is on technically challenging and commercially attractive monoclonal antibodies mAbs, in the disease areas of immunology and oncology." It also stated " Our strategy is to leverage our BioSymphony Platform to cost-effectively develop these biosimilars on an accelera."

SEEK MORE WEBSITES

IrisMystery Danielis R. - DeviantArt

Forgot Password or Username? Deviant for 5 Years. This is the place where you can personalize your profile! Across .

Naim The Blackmamba

Alas! Now consider this, the special someone is seeing another person.

prose by the lb poetry, musings, thoughts, writings, etc.

Poetry, musings, thoughts, writings, etc. There is nothing you did wrong. Nothing you could have foreseen. Children die of cancer, and babies too. All of us are dealing with the shock. The holidays are a wee bit frightful. Make the most of, make the most of.

The Crafting Cajun

Sunday, October 28, 2012. Man oh Man oh Man. do I have great tip for you. We are experiencing a beautiful, much anticipated cold front here in South Louisiana and that only means one thing. Tuesday, October 16, 2012.